Trials / Not Yet Recruiting
Not Yet RecruitingNCT06057233
Innovative MRI to Localize the Epileptic Zone
Quantitative MRI and GABA Spectroscopy to Localize the Epileptic Zone
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of EPI-CATCHER is to outline the clinical potential of multiparametric quantitative MRI (mqMRI) and of GABA-edited magnetic resonance spectroscopy (GABA-MRS), combined with machine learning tools, as imaging biomarkers to localize and delineate the EZ.
Detailed description
After informed consent, patient candidate to resection surgery will undergo two extra MRI sessions before surgery: one for multiparametric quantitative MRI (mqMRI) and one for GABA-edited magnetic resonance spectroscopy (GABA-MRS) In parallel, a group of healthy volunteers will also undergo the two MRI sessions described above, to collect reference data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | mqMRI and GABA-MRS | multiparametric quantitative MRI (mqMRI) and of GABA-edited magnetic resonance spectroscopy (GABA-MRS) |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2028-11-01
- Completion
- 2028-11-01
- First posted
- 2023-09-28
- Last updated
- 2024-08-23
Source: ClinicalTrials.gov record NCT06057233. Inclusion in this directory is not an endorsement.